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ABSTRACT  
Objectives: This study was conducted to evaluate the comparative 
effectiveness of Charakokta sauvarchaladi churna and Theo-asthalin in 
Shwas”, it aimed at evaluating the efficacy of Sauvarchaladi Churna in 
Shwas. Materials and Methods: A study was conducted and 60 patients 
were randomly selected of Shwas, attending OPD or IPD department of 
Kayachikitsa OPD was included in study and divided into 2 groups. In 
Group A 30 patients were selected and trial drug was advocated in a dose 
of 3gm twice a day with Koshna Jal as Anupana. In Group B 30 patients 
were selected, Tab Theo-Asthalin was given twice a day. Treatment was 
given for 30 days with the result assessment recorded at every 5 days. 
Subjective and objective parameters were analyzed before and after the 
treatment. In subjective parameters Pinasa, Kasa veg, Kapha Sthivan, 
Shwas Veg gati, Asino Labhate Saukhyam, Ghurghurakam, while ESR, 
Chest Expansion, Breath holding time and Peak Expiratory Flow Rate 
(PEFR) are considered as objective parameters. 
Results: Effect of the Sauverchaladi churn (Group A) and Tab. Theo-
Asthalin (Group B) on symptoms observed in Shwas is statistically 
proved to be significant. But on comparison between two groups, group A 
is more effective in reducing the symptoms Kasa veg, Kapha Sthivan, 
Shwas Veg gati, Asino Labhate Saukhyam. In reducing the symptoms 
Pinasa and Ghurghurakam there is no significant difference between two 
groups i.e. both groups are equally effective. It was observed that total 
percentage of relief in symptoms in Group A is 75.24%, whereas in Group 
B it was found 63.86%. It shows that Group A therapy of Saauvarchaladi 
churna is more effective in relieving symptoms of Shwas. 
Conclusion: Comparison between two groups was statistically evaluated 
by chi- square test. The Chi-square value 7.929 at 2 degrees of freedom, 
P<0.001 which is statistically highly significant which suggest that Group 
A was more effective than Group B. 
 
INTRODUCTION 
Ayurveda is a science of life. Each & every 
human being wants to live happy & comfortable life. 
But now a day’s life is becoming busy for Reducing 
the span of consumption of time human created 
facilities around him. For utilizing these facilities he 
got time bounded. Due to busy life, lot of work, 
negligence to health, junk foods, irregular of meals, 
lack of exercises, etc human beings are getting 
affected with various diseases. Ayurveda tell us how 
to live. In Ayurved there is Prayojan about how to 
live & how to prevent diseases. ‘Prevention is better 
than cure’ is told by Ayurveda in Hetu parimarjan 
chikitssa. 
 In Ayurveda there is description in which 
disease what to eat & how to live. Shwas disease 
arise due to dust, smoke, wind, residing in cold 
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place & using cold water, physical exertion, sexual 
intercourse, travelling on foot & intake of rough 
food & irregular meals. 
 Besides Shwas also rise, due to intake of 
Nispava, Black gram, oil cake, Sesamum & oil, flour 
preparations, tubers, distending, burning & heavy 
foods. When Vayu taking severe course reaches 
(respiratory) passages seizing neck & head & 
aggravating (Secretion of) phlegm it produces 
coryza which creates obstruction & trouble-some 
dyspnoea. 
 The patient due to severe paroxysmus 
faints, coughs with obstruction, while coughing 
becomes unconscious frequently, in absence of 
expectoration becomes too much distressed & after 
expectoration gets temporary relief. The patient of 
hiccup & dyspnoea should, at first be managed with 
unctuous sudation by the tabular, bed, & bolves 
methods after he is massaged with salted oil. By this 
his inspissated phlegm into the channels get 
dissolved & Vayu returns to its normal course. 
Sauvarchala, Sunthi, Bharangi mixed with 
double sugar should be taken with hot water. This 
alleviates hiccup & dyspnoea. ‘I came across many 
people having history of Tamak shwasa. That 
particular fact I accepted & attracted me towards 
‘Bronchial Asthma’. As the disease Shwas having 
five types one of them is ‘Tamak Shwas’.  
There are many fatal diseases but they do 
not take away the life so quickly as hiccup & 
dyspnoea. Moreover, in the person suffering from 
other various disorders severe hiccup or dyspnoea 
arises at the End. As in any acute disease as 
mentioned Earlier powerful drugs are given to treat 
the patients which plays an important & effective 
role, but in between on & off attacks there is same 
silent phase. Which is called as Avegavastha of 
Shwas. In this stage if drug like ‘Sauvarchaladi 
churna’ is plays an important role for the 
prevention of Vegavastha. Hence ‘Sauvarchaladi 
churna’ was thought to be used as a treatment. In 
the pathogenesis of the disease vat Dosha is more 
responsible in association of Kapha i.e. the drug 
‘Sauvarchaladi churna’ acts on Respiratory tract be 
Meane of Ushna’ ‘Tikshna’ & Yogvahi Guna.  
The disease is affecting very young kids also 
more in cosmopolitan & humid cities like Mumbai. 
Despite very potent bronchodilaters in the form 
injections, various types of inhalers and pumps & 
electrical nebulisers, administrating oxygen therapy 
along with the help of antihistamines & steroids. 
The severity of disease & suffering of patients goes 
on decreasing by passage of time with climatic 
changes. Here in this scenario an Ayurvedic 
practitioners thinking & working on the basis of 
fundamental principles can provide appropriate 
counselling to such patients along with proceedings. 
Hence we Ayurvedic people are required to play 
very important crucial role in the management of 
patients Of this disease (i.e. Asthma/Shwas) 
MATERIALS & METHODS  
Type of Study: Open Randomized Control Study. 
Medium of Dissertation 
English, supplemented with Ayurvedic terminology 
wherever necessary in Sanskrit. 
Ethical Clearance 
Clearance from Ethical Committee of concerned 
institute was taken. 
Consent 
 An informed written consent of all 60 
patients included in the study was taken in their 
own language. Their disease and line of treatment 
was explained to them. 
Study Centre: O.P.D. &I.P.D. of Hospital related to 
concerned Institute. 
Materials 
Group A: Sauvarchaladi Churna 
Contents –  
Sauvarchal - 1 part 
Shunthi - 1 part 
Bharangi - 1 part 
Sharkara - 2 parts 
Group B: Tab. Theo-Asthalin 
Method of Preparation of Churna 
Churna kalpana 
Powder of dried Dravya with or without any 
addition of liquid is called as Churna. Churna is any 
dry substance is brushed and made into fine 
powder by Vastra-galan i.e. poured by clothes. 
Powder can be made by disintegrator also. 
Matra: 1 Kol   
Process of Churna preparation 
Equipments: Cleaned and dried drug, mortar and 
pestle, cloth. 
Process 
The ingredients of Sauvarchaladi yog viz. 
Sauvarchal, Bharangi, Shunthi and Sharkara; were 
purchased from market and its physio-chemical 
analysis was carried out at Research Lab. After that 
all Churnas in given quantity are to be mixed 
properly to form homogeneous mixture, filtered 
through clean cloth and subjected to further study. 
All aseptic precautions were taken during the 
preparation. 
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Methodology 
Randomly selected 60 patients of Shwas, 
attending OPD or IPD department of Kayachikitsa 
OPD was included in study and divided into 2 
groups. 
Baseline Assessment 
This included a detailed history including 
family history, personal history, habits etc. Clinical 
examination including all Strotopariksha, Ashtavidh 
pariksha and Artavahastrotas pariksha were carried 
out. 
Criteria of Selection 
Inclusion criteria 
1. Selection according to age - patients in the age 
group 16 to 60 yr age. 
2. Selection according to sex - patients of both, 
male and female was selected.  
3. Patients having cardinal sign & symptoms of 
Tamakshwas avegavastha were selected.  
Exclusion criteria 
1) Patients below the age of 16 yrs and above 60 
yrs were excluded. 
2) Patients in Vegavastha as well as status 
asthmatics (very acute asthmatic attack) & 
having serious complication. 
3) Unco-operative healthy Shwas patients. 
4) Shwas with hypertensive patients. 
5) Shwas with diabetic patients. 
6) Shwas with Hridrog (cardiac disorder). 
All the patients fulfilling inclusion and 
exclusion criteria were selected for the study with 
fully informed consent. 
Plan of clinical trial 
Group A: Trial group 
No of patients – 30 
Drug – Sauvarchaladi Churna 
Dose – 3gm B.D. 
Anupana – Koshna Jal 
Duration of treatment – 30 Days  
Follow up – Each 5 Days  
Group B: - Control group 
No of patients – 30 
Drug – Tab Theo-Asthalin 
Dose – 1 tab B.D. 
Duration of treatment – 30 Days 
Follow up – Each 5 Days 
Criteria for Assessment  
Investigations: Baseline investigations required 
for screening of patients were carried out initially, 
such as CBC, ESR, LFT, RFT, BSL (fasting & 
postprandial), HIV, VDRL etc. 
Out of these investigations Hb% and ESR 
were done after completion of treatment and were 
assessed statistically. Also Peak expiratory Flow 
Rate (PEFR), Chest expansion and Breath holding 
time were recorded before and after treatment and 
assessed statistically. 
Subjective parameters: Cardinal sign and 
symptoms of the disease were noted and were used 
for assessment of the effect of treatments. 
1) Pinasa 
No Pinasa o 
Pinasa only along with attack 1 
Very often Pinasam, Even without attack 2 
Persistent Pinasam 3 
2) Kasa veg (Ativegat Kasate) 
No Kasa 0 
Kasa vega Sometimes, Not troublesome 1 
Kasa vega with pain, not disturbing the sleep 2 
Very troublesome, Does not allow to sleep 3 
3) Kaphasthevan (Quantity of sputum)  
10ml/day 0 
20ml/day 1 
30ml/day 2 
40ml/day or more 3 
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4) Shwas veg gati (Respiratory rate) 
18/min 0 
24/min 1 
30/min 2 
40/min or more 3 
5) Asino labhate Saukhyam 
Relief in lying down position & can sleep 0 
No coughing in sitting posture & can sleep 1 
Intermittent coughing in sitting posture but can sleep 2 
In sitting posture pt can’t sleep  3 
6) Ghurghurakam (Wheezing) 
No wheezing 0 
Wheezing only during attack 1 
Very often wheezing sound 2 
Wheezing throughout the day 3 
Clinical examination: Complete clinical examination from the point of view of Shwas was done to diagnose 
and assess signs and symptoms of patients. Also patients undergoing trial was examined clinically at every 
follow up to maintain record of the same. 
Case record form: Record of all the patients included in this study was documented and maintained. A case 
record form to meet all the requirements of the trial has been designed and follow up was maintained in the 
case record form. 
OBSERVATIONS 
Table 1: Age wise Distribution of 60 Patients of Shwasa 
S. No. Age Group Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1  16-30 yrs 3 10 5 16.6 8 13.3 
2 30-40 yrs 6 20 5 16.6 11 18.3 
3 40-50 yrs 10 33.3 13 43.3 23 38.3 
4 50-60 yrs 11 33.6 7 23.3 18 30 
Age -Patients included in the trial range from 16 yrs. to 60 yrs. of Age. 8 patients (13.3%) were from the age 
group 16-30 yrs. 11 patients (18.3%) were from age group 30-40 yrs. 23 patients (38.3%) were from the age 
group 40-50 yrs. 18 patients (30%) were from the age group 50-60 yrs. 
Table 2: Education wise Distribution of 60 Patients of ‘Shwasa’ 
S. No. Education Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Educated 13 43.3 9 30 22 36.6 
2 Non Educated 17 56.6 21 70 38 63.3 
Education– Out of 60 patients 22 (36.6%) patients were Educated, 38 (63.3%) patients were non-educated. 
Table 3: Occupation wise distribution of 60 Patients of ‘Shwasa’ 
S. No. Occupation Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Student 2 6.6 3 10 5 8.3 
2 Service 4 13.3 4 13.3 8 13.3 
3 Labor 18 60 14 46.6 32 53.3 
4 Housewife 6 20 9 30 15 25 
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Occupation: Out of 60 patients included in the trial 5 patients (8.3%) were Students, 8 patients (41.6%) 
were service persons, 32 patients (53.3%) were Labor and 15 patients (15%) were Housewives 
respectively. 
Table 4: Gender wise distribution of 60 Patients of ‘Shwasa’ 
S. No. Gender Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Male 16 53.3 19 63.3 35 58.3 
2 Female 14 46.6 11 36.6 25 41.6 
Gender –Out of 60 patients, 35 (58.3%) patients were male while25 (41.6%) were Female patients. 
Table 5: Socio-Economic Status wise Distribution of 60 Patients of ‘Shwasa’ 
S. No. Socio-Economic 
Status 
Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 HC 7 23.3 8 26.6 15 25 
2 MC 10 33.3 7 23.3 17 28.3 
3 LC 13 43.3 15 50 28 46.6 
Socio-Economic Status – Out of 60 patients selected in the trial 15 patients (25%) were from higher class, 
17 patients (28.3%) were of Middle class and 28 patients (46.6%) were of Lower Class. 
Table 6: Aahara (Diet) wise Distribution of 60 Patients of ‘Shwasa’ 
S. No. Aahar Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Veg 16 53.3 21 70 37 61.6 
2 Mix 14 46.6 9 30 23 38.3 
Diet – out of 60 patients included in the study 23 patients (38.3%) were having mix diet and 37 patients 
(61.6%) having vegetarian diet. 
Table 7: Prakruti wise Distribution of 60 Patients of ‘Shwasa’ 
S. No. Prakruti Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Vata – Pitta 8 26.6 11 36.6 19 31.6 
2 Pitta – Kapha 8 26.6 7 23.3 15 25 
3 Kapha – Vata 14 46.6 12 40 26 43.3 
Prakruti – out of 60 patients included in the study 19 patients (31.6%) were having Vata- Pitta dominance 
Prakruti. 15 patients (25%) having Pitta- Kapha Prakruti and 26 patients (43.3%) were having Kapha- Vata 
dominance Prakruti. 
Table 8: Agni wise Distribution of 60 Patients of ‘Shwasa’ 
S. No. Agni Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Manda 16 53.3 12 40 28 46.6 
2 Vishama 9 30 9 30 18 30 
3 Tikshna 5 16.6 9 30 14 23.3 
4 Sama 0 0 0 0 0 0 
Agni - Out of 60 patients selected in the study 28 patients (46.6%) were having Manda Agni, 18 patients 
(30%) were having Vishama Agni, 14 patients (23.3%) were having Tikshna Agni and No patient were 
observed having Sama Agni. 
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Table 9: Koshtha wise Distribution of 60 Patients of ‘Shwasa’ 
S. No.  
Koshtha 
Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 Krura 13 43.3 11 36.6 24 40 
2 Mrudu 8 26.6 11 36.6 19 31.6 
3 Madhya 9 30 8 26.6 17 28.3 
Koshtha: Out of 60 patients selected in the study24 patients (40%) were having Krura Koshtha, 19 patients 
(31.6%) were having Mrudu Koshtha and 17 patients (28.3%) were having Madhya Koshtha. 
Table 10: Chronicity wise Distribution of 60 Patients of ‘Shwasa’ 
S. No. Chronicity Group A Group B Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
1 0-1 yr 5 16.6 7 23.3 12 20 
2 1-2 yr 8 26.6 9 30 17 28.3 
3 >2 yr 17 56.6 14 46.6 31 51.6 
Chronicity – Out of 60 patients selected in the study12 patients (20%) were having disease since less than 1 
year, 17 patients (28.3%) were having since 1 to 2 years, 31patients (51.6%) were having disease since 
more than 2 years. 
Table 11: Vyasan (Addiction) wise distribution of 60 Patients of ‘Shwasa’ 
Vyasan Group (A) Group (B) Total 
No. of Pts. % No. of Pts. % No. of Pts. % 
Tobacco 6 20 5 16.6 11 36.6 
Smoking 7 23.3 5 16.6 12 20 
Alcohol 2 6.6 4 13.3 6 10 
Alcohol & Smoking / Tobacco 7 23.3 9 30 16 26.6 
No 8 26.6 7 23.3 15 25 
Vyasana - Out of 60 patients selected in the study 
11 patients (36.6%) were addicted to Tobacco, 12 
patients (20%) were addicted to Smoking, 6 
patients (10%) were having Alcohol addiction, 16 
patients (26.6%) were addicted to Alcohol as well 
as Smoking or Tobacco. 15 patients (25%) included 
in this study not having any addiction. 
Result 
Effect of the Sauverchaladi churn (Group A) 
is and Tab. Theo-Asthalin (Group B) on symptoms 
observed in Shwas is statistically proved to be 
significant. But on comparison between two groups 
there is Group A is more significant than Group B. 
Effect of the Sauvarchaladi Choorna (Group 
A) and Tab. Theo-asthalin (Group B) on symptoms 
observed in Shwas is statistically proved to be 
significant. But on comparison between two groups, 
group A is more effective in reducing the symptoms 
Kasa veg, Kapha Sthivan, Shwas Veg gati, Asino 
Labhate Saukhyam. In reducing the symptoms 
Pinasa and Ghurghurakam there is no significant 
difference between two groups i.e. both groups are 
equally effective. 
Discussion 
 The findings of clinical study are discussed 
critically as under. 
 Discussion on demographic analysis. 
 Discussion on clinical efficacy of therapy with 
symptoms. 
 Discussion on clinical efficacy of therapy on 
Objective parameters. 
 Discussion on total effect of therapy. 
 Discussion on Comparative efficacy of both 
groups. 
 Samprapti and Samprapti-bhanga. 
 Probable mode of action of drugs. 
Discussion on Demographic analysis 
1.Age: It was found that out of 60 patients of Shwas, 
13.3% of patients were from age group of 16-30 yrs. 
18.3% were from age group of 30-40 yrs.& 38.3% 
were from age group of 40-50 yrs. & 30% of 
patients were from age group of 50-60 yrs. There is 
a predominance of the patients between Age group 
of 40 to 60 years observed, because of Vata 
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Pradhanyata and Vardhakyajanya srotodaurbalya in 
this Age group is observed. (Table 1, Graph 1). 
2.Education: Out of 60 patients 22 (36.6%) 
patients were Educated,38 (63.3%) patients were 
non-educated. The percentage of Non educated 
patients is found more. (Table 2, Graph 2). 
3.Occupation: Out of 60 patients of ‘Shwas’, 5 
patients (8.3%) were students, 8 patients (13.3%) 
were service men and women, 32 patients (53.3%) 
were Labor worker and 15 patients (25%) were 
Housewives respectively. The percentage of Labor 
workers & Housewives were observed more. This 
explains labor workers and Housewives were 
exposed to dust which is major etiological factor for 
the Shwas. Also Labour workers have Sroto-
daurbalya and unhygienic condition at work, this 
may explains higher no of patients in this category. 
(Table 3, Graph 3). 
4. Gender: Out of 60 patients, 35 (58.3%) patients 
were male while25 (41.6%) were Female patients. 
Thus percentage of male patients found more in 
study. (Table 4, Graph 4). 
5. Socio-Economic status: Out of 60 patients of 
‘Shwas’, 15 patients (25%) were from higher 
economical class. 17 patients (28.3%) were from 
middle class and 28 patients (46.6%) were from 
lower Socio-economical class. More percentage of 
lower class is observed, this may be due to poor 
hygine and more exposure to dust. (Table 5, Graph 
5). 
6. Diet (Aahara): Out of 60 patients of ‘Shwas’ 37 
patients (61.6%) were having vegetarian diet and 
23 patients (38.3%) having mixed diet. (Table 6, 
Graph 6). 
7. Prakruti: Out of 60 patients of ‘Shwas’, 19 
patients (31.6%) were having Vata- pitta 
dominance Prakruti. 15 patients (25%) having 
Pitta- Kapha Prakruti and 26 patients (43.3%) were 
having Kapha- Vata dominance Prakruti. A 
predominance of Kapha vata Prakruti is observed. 
(Table 7, Graph 7) 
8. Agni: Out of 60 patients selected in the trial 28 
patients (46.6%) were having Manda Agni, 18 
patients (30%) were having Vishama Agni, 14 
patients (23.3%) were having Tikshna Agni and no 
patients were observed having Sama Agni. A more 
percentage of Mandagni patients followed by 
Vishama agni and Tikshna agni is observed. (Table 
8, Graph 8).  
9. Koshtha: Out of 60 patients selected in the trial 
24 patients (40%) were having Krura Koshtha, 19 
patients (31.6%) were having Mrudu Koshtha, 17 
patients (28.3%) were having Madhya Koshtha. A 
predominance of Krura Koshtha followed by Mrudu 
Koshtha is observed. (Table 9, Graph 9) 
10. Chronicity: Out of 60 patients selected in the 
study 12 patients (20%) were having chronicity of 
‘Shwas’ less than 1 year,17 patients (28.3%) were 
having chronicity 1 to 2 years and 31 patients 
(51.6%) were having chronicity More than 2 years. 
(Table 10, Graph 10). More percentage of patients 
having disease chronicity more than 2 years is 
observed. 
11. Vyasana (Addiction): Out of 60 patients 
selected in the study11 patients (36.6%) were 
having tobacco addiction, 12 (20%) patients were 
addicted to smoking, 6 (10%) of patient were 
having Alcohol addiction. 16 (26.6%) of patients 
were having Alcohol and Smoking/tobacco 
addiction & 15 (25%) of patients were recorded as 
non-addict. This data shows, Addiction is also one of 
the responsible factors for Shwas, Because 75% 
patient from total 60 patients were addicted to any 
of tobacco, Smoking or alcohol. (Table 11, Graph 
11)  
Discussion on clinical efficacy of therapy with 
symptoms 
It was observed that total percentage of relief in 
symptoms in Group A is 75.24%, whereas in Group 
B it was found 63.86%. 
It shows that Group A therapy of Saauvarchaladi 
churna is more effective in relieving symptoms of 
Shwas. 
Pinasa: The % of relief observed in Group A was 
64.78% and in Group B was 54.16%. 
 By applying Wilcoxon signed rank test, 
significant results were obtained in both groups. 
(Group A: Z=4.78, P<0.0001 ; Group B: Z =4.70, 
P<0.0001). 
 Kasa veg: The % of relief observed in Group A 
was 72.5% and in Group B was 63.15%.  
 By applying Wilcoxon signed rank test, 
significant results were obtained in both groups. 
(Group A: Z=4.78, P<0.0001 ; Group B: Z =4.78, 
P<0.0001). 
 Kaphasthivan: The % of relief observed in Group 
A was 71.62% and in Group B was 57.97%. 
 By applying Wilcoxon signed rank test, 
significant results were obtained in both groups. 
(Group A: Z=4.78, P<0.0001; Group B: Z =4.70, 
P<0.0001). 
 Shwas veg gati: The % of relief observed in 
Group A was 79.68% and in Group B was 
65.51%.  
 By applying Wilcoxon signed rank test, 
significant results were obtained in both groups. 
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(Group A: Z=4.78, P<0.0001; Group B: Z =4.78, 
P<0.0001). 
 Asino Labhate Saukhya: The % of relief observed 
in Group A was 81.35% and in Group B was 
62.06%.  
 By applying Wilcoxon signed rank test, 
significant results were obtained in both groups. 
(Group A: Z=4.70, P<0.0001 ; Group B: Z =4.62, 
P<0.0001). 
 Ghurghurkam: The % of relief observed in Group 
A was 84.37% and in Group B was 83.33%.  
 By applying Wilcoxon signed rank test, 
significant results were obtained in both groups. 
(Group A: Z=4.70, P<0.0001 ; Group B: Z =4.78, 
P<0.0001). 
Discussion on clinical efficacy of therapy on 
Objective parameters: To observe effect on 
Objective parameters paired ‘t’ test was applied. 
And for comparison of both groups unpaired ‘t’ test 
was applied. 
Haemoglobin: By applying Paired t test, significant 
result obtained in group A but result of group B was 
insignificant. (Group A: t=2.155, P= 0.039; Group B: 
t = 0.196, P = 0.845). 
ESR: By applying paired t test, significant results 
were obtained in both groups. (Group A: t = 5.196, 
P<0.0001; Group B: t =4.593, P<0.0001). 
Chest Expansion: By applying Paired t test, 
significant results were obtained in both groups. 
(Group A: t= 7.760, P<0.0001; Group B: t = 7.746, 
P<0.0001). 
Breath holding time: By applying paired t test, 
significant results were obtained in both groups. 
(Group A: t = 11.698, P<0.0001; Group B: t =9.302, 
P<0.0001). 
Peak Expiratory Flow Rate: By applying paired t 
test, significant results were obtained in both 
groups. (Group A: t = 11.433, P<0.0001; Group B: t 
=5.426, P<0.0001). 
From above statistical calculations it was 
observed that both treatments significant for the 
criteria like ESR, Chest Expansion, Breath holding 
time and Peak Expiratory Flow Rate (PEFR). Group 
A is also effective on Hemoglobin but group B is 
insignificant to increase hemoglobin. 
Discussion on total effect of therapy: Out of 60 
patients 21 patients were highly improved, 32 
patients were having moderate relief and 7 patients 
were mildly improved. No aggravations of 
symptoms were observed in any patient & all 
patients have above 25% relief. It clearly indicates 
that both therapies are effective in management of 
Shwas. 
Discussion on Comparative efficacy of both 
groups:- 
By Mann- Whitney test: Comparison between two 
groups with respect to symptom score was 
statistically evaluated by Mann- Whitney test. There 
was significant difference found between two 
groups for the symptoms Kasa veg, Kapha Sthivan, 
Shwas Veg gati, Asino Labhate Saukhyam. As the R1 
value of Group A is more than group B; Group A is 
more effective than Group B in relieving above 
symptoms. No significant difference found between 
two groups for the symptoms Pinasa and 
Ghurghurakam. That means both groups are equally 
effective in relieving these symptoms. 
By Unpaired t test: Comparison of objective 
parameter in both groups done by using Unpaired t 
test. There was significant difference found 
between two groups for the parameters chest 
expansion, breath holding time and PEFR. That is 
Group A is more effective than Group B in 
improving these parameters. No significant 
difference found between two groups for 
parameters Hemoglobin and ESR. That means both 
groups are equally effective in improving 
Hemoglobin and ESR. 
By Chi-square test: Comparison between two 
groups was statistically evaluated by chi- square 
test. The Chi-square value 7.929 at 2 degrees of 
freedom, P<0.001 which is statistically highly 
significant which suggest that Group A was more 
effective than Group B. 
Overall Properties of Sauvarchaladi Churna 
 Aachrya Charak mentioned ‘Sauvarchaladi 
Churna’ in ‘Shwas Chikitsa’. It contains four 
ingredients namely Sauvarchal, Bharangi, Shunthi in 
equal proportions and Sharkara 2 parts. When 
properties of all ingredients of the Churna were 
observed at a time it has seen that, majority of 
drugs are of Katu, Tikta & Madhur rasa, Katu vipaka 
and Ushna virya which are having potent 
Kaphaghna & Vataghna properties. While observing 
overall Gunas of all the contents, it is found that 
most of the drugs having Laghu guna. 
CONCLUSION 
 The Drug “Savurachaladi choorna” in 
Avegavastha of Tamakshwas is useful in 
Kaphapradhan tamksh was than that of 
Vatapradhan. The Drug Savurchaladi Choorna in 
Avegavastha of Tamakshwasa shows significant 
relief in Lakshana. This drug is effective in Tamak 
shwas, further research is necessary. 
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